Prospective Study of Histoplasmosis in Patients Infected with Human Immunodeficiency Virus: Incidence, Risk Factors, and Pathophysiology
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Histoplasmosis is a common opportunistic infection in patients with human immunodeficiency virus (HIV) infection who reside in areas where Histoplasma capsulatum is endemic. We undertook a prospective study of a cohort of 304 HIV-Infected patients in Kansas City from October 1990 through March 1993 to define the incidence-specific risk factors, and pathophysiology of histoplasmosis. The annual incidence of histoplasmosis was 4.7%; 74% of the patients with histoplasmosis were symptomatic (all of whom had disseminated disease). A history of exposure to chicken coops, a positive baseline serology for complement-fixing antibodies to Histoplasma mycelium antigen, and a baseline CD4+ lymphocyte count of < 150/microL were associated with an increased risk for histoplasmosis. Histoplasmin reactivity and the presence of pulmonary calcifications were not useful markers for patients at high risk. Symptomatic infection occurred in 9.9% of patients with evidence of prior exposure to H. capsulatum, in 4.0% of patients without documented prior exposure, and in 3.0% of patients who were anergic; these findings suggest that the pathophysiology of histoplasmosis in patients with AIDS involves reactivation of latent infection in some cases and dissemination of exogenously acquired infection in other cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHEAT, L. J., CONNOLLY-STRINGFIELD, P. A., BAKER, R. L., CURFMAN, M. F., EADS, M. E., ISRAEL, K. S., NORRIS, S. A., WEBB, D. H., & ZECKEL, M. L. (1990) · Medicine · doi:10.1097/00005792-199011000-00004 · Cited by 651
Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S. L., Eyster, M. E., Carey, J., Waskin, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321102 · Cited by 318
Risk Factors for Disseminated or Fatal Histoplasmosis: Analysis of a Large Urban Outbreak
WHEAT, L. J., SLAMA, T. G., NORTON, J. A., KOHLER, R. B., EITZEN, H. E., FRENCH, M. L. V., & SATHAPATAYAVONGS, B. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-159 · Cited by 196 · cited 2×
“Cellular immunodeficiency, a known risk factor for disseminated histoplasmosis in HIV-seronegative individuals [13-15], is common in patients with AIDS and histoplasmosis [2, 16, 17].”
Background
Cited by
Histoplasmosis: a Clinical and Laboratory Update
Kauffman, C. A. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-06 · Cited by 1,200
“Patients with CD4 counts of 150 cells/ l are at most risk (52, 87).”
BackgroundHistoplasmosis in Africa: An emerging or a neglected disease?
Oladele, R. O., Ayanlowo, O. O., Richardson, M. D., & Denning, D. W. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006046 · Cited by 192
“A past history of cave exploration; presence at and/or participation in excavation sites; woodcut-ting; and exposure to bird roosts, farms, or poultry have also been documented [31].”
BackgroundEndemic Mycoses: Blastomycosis, Histoplasmosis, and Sporotrichosis
Kauffman, C. A. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.002 · Cited by 113
Metadata
- Authors
- McKinsey, D. S., Spiegel, R. A., Hutwagner, L., Stanford, J., Driks, M. R., Brewer, J., Gupta, M. R., Smith, D. L., O'Connor, M. C., & Dall, L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-06
- Volume
- 24
- Issue
- 6
- Pages
- 1195-1203
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2129353565
- Cited by
- 167
- References
- 3
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.